US Stocks - Insider Trading disclosures made on May 27, 2025

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	207,669	0	-	2.0	409,108	Ordinary Shares
GAN Limited 52 week high	Seamus McGill	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	206,250	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Eric J. Green	Director	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	153,089	0	-	2.0	301,585	Ordinary Shares
GAN Limited 52 week high	Seamus McGill	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	144,256	0	-	2.0	284,184	Ordinary Shares
GAN Limited 52 week high	David Goldberg	Director	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	137,411	0	-	2.0	270,700	Ordinary Shares
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	110,201	0	-	2.0	217,096	Ordinary Shares
GAN Limited 52 week high	Susan Bracey	Director	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	100,686	0	-	2.0	198,351	Ordinary Shares
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	91,690	0	-	2.0	180,629	Ordinary Shares
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	83,430	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Giuseppe Gardali	President, B2B	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	82,507	0	-	2.0	162,539	Ordinary Shares
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	81,846	0	-	2.0	161,237	Ordinary Shares
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	68,492	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	60,000	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 1.97 per share.	27 May 2025	59,747	0	-	2.0	117,702	Ordinary Shares
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	59,747	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	53,570	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	52,339	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	52,170	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Seamus McGill	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	50,000	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Giuseppe Gardali	President, B2B	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	39,306	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	37,852	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	37,303	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	35,762	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	33,020	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Giuseppe Gardali	President, B2B	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	21,018	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	19,133	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	17,123	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Jan Roos	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	16,318	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Giuseppe Gardali	President, B2B	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	15,850	0	-		-	Restricted Stock Units
Compass Therapeutics Inc	Thomas J. Schuetz	Director, CHIEF EXECUTIVE OFFICER	Purchase of securities on an exchange or from another person at price $ 2.11 per share.	27 May 2025	10,000	6,480,825	-	2.1	21,100	Common Stock
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	8,000	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	7,065	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	6,321	0	-		-	Employee Stock Option (right to buy)
GAN Limited 52 week high	Giuseppe Gardali	President, B2B	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	6,031	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Sylvia Tiscareno	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	3,890	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Brian Chang	CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	2,535	0	-		-	Restricted Stock Units
GAN Limited 52 week high	Endre Nesset	President, B2C	Sale or transfer of securities back to the company at price $ 0.00 per share.	27 May 2025	2,000	0	-		-	Employee Stock Option (right to buy)
BCB Bancorp Inc (NJ)	James G. Rizzo	Director	Purchase of securities on an exchange or from another person at price $ 8.05 per share.	27 May 2025	1,500	60,708 (0%)	0%	8.1	12,075	Common Stock
BCB Bancorp Inc (NJ)	James G. Rizzo	Director	Purchase of securities on an exchange or from another person at price $ 8.05 per share.	27 May 2025	1,500	73,554 (0%)	0%	8.1	12,075	Common Stock
Lilly(Eli) & Co Acquisition	Donald A. Zakrowski	SVP, Finance, & CAO	Sale of securities on an exchange or to another person at price $ 716.41 per share.	27 May 2025	1,000	4,839 (0%)	0%	716.4	716,410	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

US Stocks - Insider Trading disclosures made made on May 27, 2025

View 40 US Stocks - Insider Trading disclosures made on US Exchanges on May 27, 2025.

The latest disclosure under SEC insider trading regulations was reported by GAN Limited., where the revocation of 207,669 Ordinary Shares of common stock was executed at an average price of $2.0. This transaction was reported to the Securities and Exchange Commission on May 27, 2025.

Screeners based on Insider Trading parameters